Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
REVENUES    
Neurometric Information Services $ 115,000 $ 111,400
OPERATING EXPENSES:    
Cost of Neurometric Service revenues 132,000 147,100
Research 264,500 482,800
Product development 589,200 442,000
Sales and marketing 997,100 1,132,800
General and administrative 2,938,100 3,197,900
Total operating expenses 4,920,900 5,402,600
OPERATING LOSS (4,805,900) (5,291,200)
OTHER INCOME (EXPENSE):    
Interest income (expense), net (4,123,200) (7,567,000)
Loss on extinguishment of debt 0 (1,968,000)
Financing fees (151,500) (348,600)
Offering costs (784,100) (437,800)
Other non-operating income 0 458,800
Gain on derivative liabilities 6,950,300 6,826,700
Total other income (expense) 1,891,500 (3,035,900)
LOSS BEFORE PROVISION FOR INCOME TAXES (2,914,400) (8,327,100)
Provision for income taxes 1,900 1,300
LOSS BEFORE OTHER COMPREHENSIVE INCOME (2,916,300) (8,328,400)
Other Comprehensive Income (Loss) 0 0
LOSS FROM CONTINUING OPERATIONS (2,916,300) (8,328,400)
Loss from discontinued operations (490,500) (538,200)
NET LOSS $ (3,406,800) $ (8,866,600)
BASIC LOSS PER SHARE:    
From continuing operations (in dollars per share) $ (1.55) $ (4.45)
From discontinued operations (in dollars per share) $ (0.26) $ (0.29)
Combined Net Loss (in dollars per share) $ (1.81) $ (4.74)
DILUTED LOSS PER SHARE:    
From continuing operations (in dollars per share) $ (1.55) $ (4.45)
From discontinued operations (in dollars per share) $ (0.26) $ (0.29)
Combined Net Loss (in dollars per share) $ (1.81) $ (4.74)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic (in shares) 1,887,508 1,869,038
Diluted (in shares) 1,887,508 1,869,038